Back to Search
Start Over
Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin
- Source :
- PR Newswire. October 22, 2024
- Publication Year :
- 2024
-
Abstract
- Active Ingredient in HyBryte(TM) for the Treatment of Cutaneous T-Cell Lymphoma and SGX302 for the Treatment of Psoriasis PRINCETON, N.J., Oct. 22, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.813126867